Top Wall Street Predictors renew further than the air expectations prior to Q4 income – Beyond Air (Nasdaq: Xair)

Beyond Air, Inc. Xair Will release his fourth quarter of financial results after the final bell on Tuesday 17 June.

Analysts expect that the company, based in New York, will report quarterly turnover of $ 1.39 million, compared to $ 470,000 a year earlier, according to data from Petrol.

On April 21, Air announced that his subsidiary Neuronos received an FDA Orphan Drug indication.

Beyond Air shares fell by 3% to close at $ 0.1779 on Friday.

Benzinga readers have access to the latest analyst reviews on the Analyst Stock Ratings page. Readers can sort on stock ticker, company name, analyst company, rating change or other variables.

Let’s see how Benzinga’s most accurate analysts have assessed the company in the past period.

The best financial deals of today

• BTFT analyst Marie Thibault has lowered the shares from Buy to Neutral on 25 June 2024. This analyst has an accuracy rate of 63%.
• Truist effects analyst Gregory Fraser held a buy -rating and reduced the price target from $ 10 to $ 8 to 30 April 2024. This analyst has an accuracy rate of 63%.

Is you considering buying Xair shares? This is what analysts think:

Read this following:

Photo via Shutterstock